Search

5 results for “off-label indications”

• EditorialOpen Access

  Are we moving towards a new definition of essential medicines?

  Manikandan S

  Vol. 6 · Issue 3 · pp. 123–5

  https://doi.org/10.4103/0976-500X.162008
  Full text ↗PDF

• Review ArticleOpen Access

  An In-depth Review of the Off-label Use of Apremilast in Dermatology

  Aditya Kumar Bubna, Vinayak Viplav

  Vol. 16 · Issue 2 · pp. 143–163

  https://doi.org/10.1177/0976500X241303186
  Full text ↗PDF

• News and ViewsOpen Access

  Antidepressants

  G. Sivagnanam

  Vol. 3 · pp. 287–288

  Full text ↗PDF

• Case ReportOpen Access

  Dalbavancin Use for the Treatment of Methicillin-resistant Staphylococcus aureus Pneumonia

  Katie E. Barber, Amir Tirmizi, Richard Finley, Kayla R. Stover

  Vol. 8 · Issue 2 · pp. 77–9

  https://doi.org/10.4103/jpp.JPP_2_17
  Full text ↗PDF

• Educational ForumOpen Access

  Off‑label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities

  Sandeep Kumar Gupta, Roopa Prasad Nayak

  Vol. 5 · Issue 2 · pp. 88–92

  https://doi.org/10.4103/0976-500X.130046
  Full text ↗PDF